Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management
Ayalew Tefferi
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
58
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Primary Myelofibrosis
100%
Risk Management
87%
INCB018424
41%
Extramedullary Hematopoiesis
38%
Mutation
29%
Splenomegaly
29%
Survival
29%
Karyotype
27%
Anemia
22%
Stem Cells
19%
Bone Marrow
19%
Danazol
18%
Reticulin
18%
Thalidomide
16%
Cachexia
16%
Hydroxyurea
16%
Splenectomy
14%
Allogeneic Cells
14%
Prednisone
13%
Therapeutics
13%
Androgens
12%
Fibrosis
9%
Extremities
9%
Observation
9%
Radiotherapy
9%
Clinical Trials
8%
Transplants
8%
Cytokines
8%
Bone and Bones
7%
Pain
7%
Pharmaceutical Preparations
5%
Neoplasms
4%